Summary
KLA Corporation (KLAC) filed an 8-K on March 15, 2007, to disclose significant changes in its equity award grant procedures. These changes stem from a Special Committee investigation into the company's historical stock option practices. In response to the investigation, the Board of Directors suspended the use of any stock option committee and delegated sole authority for granting stock options and restricted stock awards to the full Compensation Committee, subject to Board ratification. The grant date is now fixed as the Compensation Committee approval date, with exercise or valuation prices set at the closing market price on that date. Furthermore, the Compensation Committee approved and the Board ratified a new policy in February 2007 that formalizes and enhances these procedures. Key elements include annual reviews of dilution targets and plan design, quarterly approvals of awards at scheduled meetings, specific procedures for non-routine grants (like executive hires), and strengthened administrative processes to ensure accurate grant dates, pricing, and record-keeping. These measures are designed to improve governance and transparency surrounding equity compensation.
Key Highlights
- 1KLA-Tencor's Board of Directors has suspended the use of stock option committees following an investigation into historical stock option practices.
- 2Sole authority for granting stock options and restricted stock awards is now delegated to the full Compensation Committee, subject to Board ratification.
- 3Grant date for equity awards is now officially the date of Compensation Committee approval.
- 4The exercise price for stock options and valuation price for restricted stock is set at the closing market price on the grant date.
- 5A new equity award grant policy was approved in February 2007, formalizing and enhancing grant procedures.
- 6The new policy includes annual reviews of equity award dilution targets and plan design.
- 7Equity awards will be approved quarterly by the Compensation Committee at regularly scheduled meetings, with provisions for non-routine approvals.